Quantitative proteomics assay reveals G protein-coupled receptor kinase 4-induced HepG2 cell growth inhibition

Yunxiu Luo1,2, Jing Yang3, Yan Wang4

  • 1Hainan Cancer Hospital, Affiliated Cancer Hospital of Hainan Medical University, Department of Radiotherapy Oncology, Haikou, 570311, China.

Heliyon
|April 19, 2024
PubMed
Abstract

Insights

G protein-coupled receptor kinase 4 (GRK4) inhibits HepG2 cell proliferation and induces S-phase cell cycle arrest. The peroxisome proliferator-activated receptor (PPAR) pathway is implicated in GRK4-mediated regulation of these cells.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Proteomics

Background:

  • G protein-coupled receptor kinase 4 (GRK4) is a key regulator of G protein-coupled receptor signaling.
  • Understanding GRK4's role in cellular processes is crucial for deciphering its biological effects.

Purpose of the Study:

  • To investigate the biological effects of GRK4 on HepG2 cells.
  • To elucidate the underlying biological mechanism of GRK4 action.

Main Methods:

  • HepG2 cells were infected with GRK4-overexpressing (OE) or negative control (NC) lentivirus vectors.
  • Cell proliferation, cell cycle, and apoptosis were assessed using Cell Counting Kit-8 and flow cytometry (FCM).
  • Quantitative proteomics and parallel reaction monitoring (PRM) were employed to analyze protein expression profiles and identify differentially expressed proteins (DEPs).

Main Results:

  • GRK4 overexpression led to reduced HepG2 cell proliferation and S-phase cell cycle arrest.
  • No significant apoptosis was observed in either OE or NC cells.
  • Proteomic analysis identified 403 DEPs, with 135 downregulated and 268 upregulated, many involved in the peroxisome proliferator-activated receptor (PPAR) signaling pathway.

Conclusions:

  • GRK4 inhibits HepG2 cell proliferation and induces S-phase cell cycle arrest.
  • The PPAR signaling pathway plays a role in GRK4-mediated regulation of HepG2 cells.